These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 4712542

  • 1. Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.
    Rinne UK, Sonninen V, Siirtola T.
    Eur Neurol; 1973; 9(6):349-62. PubMed ID: 4712542
    [No Abstract] [Full Text] [Related]

  • 2. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
    Gumpert J, Sharpe D, Curzon G.
    J Neurol Sci; 1973 May; 19(1):1-12. PubMed ID: 4715017
    [No Abstract] [Full Text] [Related]

  • 3. Central monoamine metabolism in Parkinson's disease.
    Chase TN, Ng LK.
    Arch Neurol; 1972 Dec; 27(6):486-91. PubMed ID: 5083866
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Parkinson's disease. Modification by 5-hydroxytryptophan.
    Chase TN, Ng LK, Watanabe AM.
    Neurology; 1972 May; 22(5):479-84. PubMed ID: 4563493
    [No Abstract] [Full Text] [Related]

  • 6. 5-Hydroxyindoleacetic acid in cerebrospinal fluid of patients with Parkinson's syndrome treated with L dopa.
    Johansson B, Roos BE.
    Eur J Clin Pharmacol; 1971 Sep; 3(4):232-5. PubMed ID: 5151306
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonism.
    Chase TN, Watanabe AM.
    Neurology; 1972 Apr; 22(4):384-92. PubMed ID: 5062828
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
    Pullar IA, Dowson JH, Ahmed R, Chow R, Gillingham FJ.
    Confin Neurol; 1972 Apr; 34(2):143-8. PubMed ID: 4666057
    [No Abstract] [Full Text] [Related]

  • 12. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
    Garelis E, Young SN, Lal S, Sourkes TL.
    Brain Res; 1974 Oct 11; 79(1):1-8. PubMed ID: 4279131
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
    Mendlewicz J, Vanderheyden JE, Noel G.
    Adv Exp Med Biol; 1981 Oct 11; 133():753-67. PubMed ID: 6172024
    [Abstract] [Full Text] [Related]

  • 15. Modification of levodopa effect by systemic decarboxylase inhibition.
    Mars H.
    Arch Neurol; 1973 Feb 11; 28(2):91-5. PubMed ID: 4683155
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.
    Rinne UK, Sonninen V, Sirtola T.
    Z Neurol; 1972 Feb 11; 202(1):1-20. PubMed ID: 4114458
    [No Abstract] [Full Text] [Related]

  • 17. Levodopa: alterations in behavior.
    Goodwin FK, Murphy DL, Brodie HK, Bunney WE.
    Clin Pharmacol Ther; 1971 Feb 11; 12(2):383-96. PubMed ID: 4930867
    [No Abstract] [Full Text] [Related]

  • 18. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA, Mandarini A, Campanella G, Carrieri P, Orefice G.
    Acta Neurol (Napoli); 1976 Feb 11; 31(5):565-70. PubMed ID: 138340
    [No Abstract] [Full Text] [Related]

  • 19. Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid.
    Chase RN, Schnur JA, Brody JA, Gordon EK.
    Arch Neurol; 1971 Jul 11; 25(1):9-13. PubMed ID: 5146413
    [No Abstract] [Full Text] [Related]

  • 20. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ, Somerville B.
    Med J Aust; 1974 Mar 23; 1(12):429-32. PubMed ID: 4598384
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.